Literature DB >> 27784786

Nrf2 Transcription Factor Can Directly Regulate mTOR: LINKING CYTOPROTECTIVE GENE EXPRESSION TO A MAJOR METABOLIC REGULATOR THAT GENERATES REDOX ACTIVITY.

Gabriel Bendavit1, Tahar Aboulkassim1, Khalid Hilmi1, Sujay Shah1, Gerald Batist2.   

Abstract

Nrf2 is a master transcription factor that regulates a wide variety of cellular proteins by recognizing and binding to antioxidant response elements (AREs) in their gene promoter regions. In this study we show that increasing cellular Nrf2 results in transcriptional activation of the gene for mTOR, which is central to the PI3K signaling pathway. This is the case in cells with normal physiological PI3K. However, in cells with abnormally active PI3K increased cellular Nrf2 levels have no effect on mTOR. ChIP assays results show that increased Nrf2 binding is associated with decreased p65 binding and H3-K27me3 signal (marker of gene repression) as well as increased H3-K4me3 signal (marker of gene activation). However, in cells with PI3K activation, no effect of cellular Nrf2 increase on mTOR transcription was observed. In these cells, increasing Nrf2 levels increases Nrf2 promoter binding marginally, whereas p65 binding and H3-K27me3 mark were significantly increased, and H3-K4me3 signal is reduced. Together, these data show for the first time that Nrf2 directly regulates mTOR transcription when the PI3K pathway is intact, whereas this function is lost when PI3K is activated. We have identified a link between the Nrf2 system of sensing environmental stress and mTOR, which is a key cellular protein in metabolism. Studies in cells with activating mutations in the PI3K pathway suggest that Nrf2 transcriptional regulation of mTOR is related to promoter binding of p65 and of methylation of histone residues permissive of transcription.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  NF-κB (NF-KB); histone methylation; mammalian target of rapamycin (mTOR); nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); phosphatidylinositol kinase (PI kinase)

Mesh:

Substances:

Year:  2016        PMID: 27784786      PMCID: PMC5207248          DOI: 10.1074/jbc.M116.760249

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

2.  Autophagy Deficiency Diminishes Indomethacin-Induced Intestinal Epithelial Cell Damage through Activation of the ERK/Nrf2/HO-1 Pathway.

Authors:  Satoshi Harada; Takatoshi Nakagawa; Shunichi Yokoe; Shoko Edogawa; Toshihisa Takeuchi; Takuya Inoue; Kazuhide Higuchi; Michio Asahi
Journal:  J Pharmacol Exp Ther       Date:  2015-09-24       Impact factor: 4.030

3.  NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma.

Authors:  David W Cescon; Desmond She; Shingo Sakashita; Chang-Qi Zhu; Melania Pintilie; Frances A Shepherd; Ming-Sound Tsao
Journal:  Clin Cancer Res       Date:  2015-03-04       Impact factor: 12.531

4.  Histone H3 lysine 4 methylation patterns in higher eukaryotic genes.

Authors:  Robert Schneider; Andrew J Bannister; Fiona A Myers; Alan W Thorne; Colyn Crane-Robinson; Tony Kouzarides
Journal:  Nat Cell Biol       Date:  2003-12-07       Impact factor: 28.824

Review 5.  Enhancing Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: Cotargeting Signaling Pathways.

Authors:  Stephen R D Johnston
Journal:  J Natl Cancer Inst       Date:  2015-08-06       Impact factor: 13.506

Review 6.  Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis.

Authors:  Wenge Li; Tin Oo Khor; Changjiang Xu; Guoxiang Shen; Woo-Sik Jeong; Siwang Yu; Ah-Ng Kong
Journal:  Biochem Pharmacol       Date:  2008-07-23       Impact factor: 5.858

7.  ARE- and TRE-mediated regulation of gene expression. Response to xenobiotics and antioxidants.

Authors:  T Xie; M Belinsky; Y Xu; A K Jaiswal
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

8.  Influence of Nrf2 genotype on pulmonary NF-kappaB activity and inflammatory response after traumatic brain injury.

Authors:  Wei Jin; Lin Zhu; Qun Guan; Gang Chen; Qing Feng Wang; Hong Xia Yin; Chun Hua Hang; Ji Xin Shi; Han Dong Wang
Journal:  Ann Clin Lab Sci       Date:  2008       Impact factor: 1.256

Review 9.  Targeting the mTOR signaling pathway in neuroendocrine tumors.

Authors:  Jennifer Chan; Matthew Kulke
Journal:  Curr Treat Options Oncol       Date:  2014-09

10.  Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha.

Authors:  Brian N Chorley; Michelle R Campbell; Xuting Wang; Mehmet Karaca; Deepa Sambandan; Fatu Bangura; Peng Xue; Jingbo Pi; Steven R Kleeberger; Douglas A Bell
Journal:  Nucleic Acids Res       Date:  2012-05-11       Impact factor: 16.971

View more
  21 in total

Review 1.  Crosstalk between the mTOR and Nrf2/ARE signaling pathways as a target in the improvement of long-term potentiation.

Authors:  Artem P Gureev; Vasily N Popov; Anatoly A Starkov
Journal:  Exp Neurol       Date:  2020-03-10       Impact factor: 5.330

2.  SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas.

Authors:  Arianna L Kim; Jung Ho Back; Sandeep C Chaudhary; Yucui Zhu; Mohammad Athar; David R Bickers
Journal:  J Invest Dermatol       Date:  2018-03-14       Impact factor: 8.551

3.  The transcription factor MZF1 differentially regulates murine Mtor promoter variants linked to tumor susceptibility.

Authors:  Shuling Zhang; Wei Shi; Edward S Ramsay; Valery Bliskovsky; Adrian Max Eiden; Daniel Connors; Matthew Steinsaltz; Wendy DuBois; Beverly A Mock
Journal:  J Biol Chem       Date:  2019-09-23       Impact factor: 5.157

Review 4.  Modulating NRF2 in Disease: Timing Is Everything.

Authors:  Matthew Dodson; Montserrat Rojo de la Vega; Aram B Cholanians; Cody J Schmidlin; Eli Chapman; Donna D Zhang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-09-26       Impact factor: 13.820

5.  CHML is an NRF2 target gene that regulates mTOR function.

Authors:  Matthew Dodson; Wujing Dai; Annadurai Anandhan; Cody J Schmidlin; Pengfei Liu; Nathan C Wilson; Yongyi Wei; Naoya Kitamura; James J Galligan; Aikseng Ooi; Eli Chapman; Donna D Zhang
Journal:  Mol Oncol       Date:  2022-02-28       Impact factor: 7.449

Review 6.  Milk's Role as an Epigenetic Regulator in Health and Disease.

Authors:  Bodo C Melnik; Gerd Schmitz
Journal:  Diseases       Date:  2017-03-15

7.  Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.

Authors:  Rong Wang; Zhen Yu; Bharath Sunchu; James Shoaf; Ivana Dang; Stephanie Zhao; Kelsey Caples; Lynda Bradley; Laura M Beaver; Emily Ho; Christiane V Löhr; Viviana I Perez
Journal:  Aging Cell       Date:  2017-03-31       Impact factor: 9.304

8.  IL-1β increases asporin expression via the NF-κB p65 pathway in nucleus pulposus cells during intervertebral disc degeneration.

Authors:  Shengjie Wang; Chao Liu; Zhongyi Sun; Peng Yan; He Liang; Kai Huang; Changwei Li; Jiwei Tian
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

Review 9.  Development of targeted therapy of NRF2high esophageal squamous cell carcinoma.

Authors:  Chorlada Paiboonrungruang; Emily Simpson; Zhaohui Xiong; Caizhi Huang; Jianying Li; Yahui Li; Xiaoxin Chen
Journal:  Cell Signal       Date:  2021-08-04       Impact factor: 4.850

10.  Systems-Level Feedbacks of NRF2 Controlling Autophagy upon Oxidative Stress Response.

Authors:  Orsolya Kapuy; Diána Papp; Tibor Vellai; Gábor Bánhegyi; Tamás Korcsmáros
Journal:  Antioxidants (Basel)       Date:  2018-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.